70370-5250 : Crenessity 50 mg/ml Oral Solution
| NDC: | 70370-5250 |
| Labeler: | Neurocrine Biosciences, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Crenessity |
| Dosage Form: | Oral Solution |
| Application #: | NDA218820 |
| Rev. Date: |
NDC Package Codes:
- 70370-5250-1: 60 ML IN 1 BOTTLE (70370‑5250‑1)
Active Ingredients:
- Crinecerfont
Dosage Strength:
- 50 mg/mL
Related Products:
Based on records with the same trade name.- 70370-5025 Crenessity 25 mg Oral Capsule by Neurocrine Biosciences, Inc.
- 70370-5050 Crenessity 50 mg Oral Capsule by Neurocrine Biosciences, Inc.
- 70370-5100 Crenessity 100 mg Oral Capsule by Neurocrine Biosciences, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70370-5100Next: 70372-722 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.